Evidence map›Paper›PMID 35415186›Full record

ArticleERJ open research2022

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.

Natalie Lorent, Yannick Vande Weygaerde, Eveline Claeys, Ipek Guler Caamano Fajardo, Nicolas De Vos, Walter De Wever, Bihiyga Salhi, Iwein Gyselinck, Cedric Bosteels, Bart N Lambrecht and 15 more

Abstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Objective and subjective cognitive outcomes one year after COVID-19.Annals of clinical and translational neurology · 2024
    Article
  14. Article
  15. Cardiopulmonary Complications after Pulmonary Embolism in COVID-19.International journal of molecular sciences · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Natalie LorentDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-2653-5885
Yannick Vande WeygaerdeDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0002-8156-9420
Eveline ClaeysDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Ipek Guler Caamano FajardoLeuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), KU Leuven, Leuven, Belgium.
Nicolas De VosDept of Radiology, Ghent University Hospital, Ghent, Belgium.
Walter De WeverDept of Radiology, University Hospitals Leuven, Leuven, Belgium.
Bihiyga SalhiDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Iwein GyselinckDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Cedric BosteelsDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Bart N LambrechtDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Stephanie EveraertsDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0003-2646-4770
Sven VerschraegenDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Christophe SchepersDept of Radiology, University Hospitals Leuven, Leuven, Belgium.
Heleen DemeyerDept of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Arne HeynsDept of Physical Medicine and Rehabilitation, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-7455-2762
Pieter DepuydtDepartment of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Sandra OeyenDepartment of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Pascal Van BleyenberghDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Laurent GodinasDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Lieven DupontDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
Greet HermansDept of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
Eric DeromDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Rik GosselinkDepartment of Intensive Care, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0003-0444-8606
Wim JanssensDept of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0003-1830-2982
Eva Van BraeckelDept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.ORCID https://orcid.org/0000-0002-7242-0747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are needed to understand their recovery trajectory and additional care needs. Methods: A prospective observational multicentre cohort study was carried out of adults hospitalised with COVID-19 from March through May 2020. Workup at 3 and 12 months following admission consisted of clinical review, pulmonary function testing, 6-min walk distance (6MWD), muscle strength, chest computed tomography (CT) and quality of life questionnaires. We evaluated factors correlating with recovery by linear mixed effects modelling. Results: Of 695 patients admitted, 299 and 226 returned at 3 and 12 months, respectively (median age 59 years, 69% male, 31% severe disease). About half and a third of the patients reported fatigue, dyspnoea and/or cognitive impairment at 3 and 12 months, respectively. Reduced 6MWD and quadriceps strength were present in 20% and 60% at 3 months Conclusion: Many COVID-19 survivors, especially those with severe disease, experienced limitations at 3 months. At 1 year, the majority showed improvement to almost complete recovery. To identify additional care or rehabilitation needs, we recommend a timely multidisciplinary follow-up visit following COVID-19 admission.

Identifiers

PMID35415186
PMCPMC8994962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.